V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005737 | 330007488 | null | 12.3 | Not known (9) | 2015-11-23 | 2015-11-23 | Gemcitabine + Capecitabine | N | null | 330024649 | ABIRATERONE |
| 330005738 | 330002724 | 1.58 | 54.5 | Curative (C) | 2015-06-07 | 2015-06-14 | EDP + MITOTANE | Y | N | 330024655 | UKALL2014 |
| 330005739 | 330002725 | 1.66 | 96 | Disease modification (D) | 2014-07-08 | 2014-07-17 | Azacitidine | 2 | N | 330024668 | NILOTINIB |
| 330005740 | 330002726 | 1.84 | 630 | Disease modification (D) | 2016-04-27 | 2016-04-28 | Bortezomib (weekly) | null | null | 330024670 | CHOP |
| 330005741 | 330002727 | 1.77 | 125.5 | Curative (C) | null | 2016-06-30 | Hydroxycarbamide | N | N | 330024671 | TEMOZOLOMIDE |
| 330005742 | 330002728 | 1.71 | 66 | Palliative (P) | 2014-06-11 | 2014-06-19 | ALL UKALL2011 Maintenance B1 | N | N | 330024675 | METHOTREXATE |
| 330005743 | 330002729 | null | 44 | Curative (C) | null | 2015-01-20 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 330024676 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL |
| 330005744 | 330002729 | 0 | 58.85 | Disease modification (D) | null | 2017-09-18 | CARBOPLATIN + RT | null | null | 330024676 | MITOTANE |
| 330005745 | 330002729 | 0 | 86.2 | Neo-adjuvant (N) | 2015-03-04 | 2015-03-15 | Hydroxycarbamide | 02 | N | 330024676 | MIFAMURTIDE |
| 330005746 | 330002729 | 1.64 | 109 | Curative (C) | 2015-10-04 | 2015-10-05 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 330024676 | CVP |
| 330005747 | 330002729 | null | null | Palliative (P) | 2013-08-01 | 2013-08-01 | Cyclophosphamide Weekly PO | null | null | 330024676 | DOCETAXEL + GEMCITABINE |
| 330005748 | 330002729 | 0 | null | Curative (C) | 2017-04-07 | 2017-04-12 | AML Int Guide ADE 10+3+5 (1) | null | null | 330024676 | CAPECITABINE + CARBOPLATIN |
| 330005749 | 330002729 | 1.65 | 87 | Curative (C) | 2015-05-21 | 2015-05-21 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | 2 | null | 330024676 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 330005750 | 330002730 | 1.64 | 78.55 | Curative (C) | null | 2014-06-05 | DOCETAXEL + GEMCITABINE | null | null | 330024712 | METHOTREXATE |
| 330005751 | 330002731 | 0 | 10.8 | Palliative (P) | null | 2018-05-04 | Azacitidine | 2 | N | 330024720 | DOXORUBICIN + IFOSFAMIDE |
| 330005752 | 330002732 | 1.6 | 97.5 | Curative (C) | 2016-10-12 | 2016-10-24 | IPILIMUMAB + NIVOLUMAB | 02 | N | 330024723 | EVEROLIMUS |
| 330005753 | 330002733 | 1.75 | 64.8 | Palliative (P) | 2016-09-14 | 2016-09-29 | Capecitabine (14 days)+Carboplatin | N | N | 330024726 | MITOTANE |
| 330005754 | 330007490 | 0 | 14.5 | Not known (9) | 2017-04-07 | 2017-04-10 | METHOTREXATE | 2 | null | 330024727 | AML19 TRIAL |
| 330005755 | 330007490 | 0 | 75.2 | Palliative (P) | 2013-10-20 | 2013-11-20 | ABVD | N | N | 330024727 | EDP + MITOTANE |
| 330005756 | 330007490 | 1.75 | null | Neo-adjuvant (N) | null | 2013-10-23 | Azacitidine | null | null | 330024727 | ETOPOSIDE + RITUXIMAB |
| 330005757 | 330002734 | 1.77 | 52.4 | Palliative (P) | 2016-06-11 | 2016-06-14 | ALL UKALL2011 Ind A Sht Dex (PAsp) | N | N | 330024755 | POMB/ACE |
| 330005758 | 330002735 | 0 | 60.4 | null | 2013-02-14 | 2013-02-14 | Methotrexate intrathecal | 02 | N | 330024769 | UKALL2014 |
| 330005759 | 330002735 | null | 65.2 | Palliative (P) | 2015-07-04 | 2015-07-04 | PEMBROLIZUMAB | N | N | 330024769 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 330005760 | 330002736 | 0 | 91 | Palliative (P) | 2014-04-05 | 2014-04-20 | IMATINIB | N | N | 330024778 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330005761 | 330007492 | null | 92 | null | null | 2014-03-21 | BCG Intravesical | null | null | 330024785 | CISPLATIN + DOCETAXEL |
| 330005762 | 330007492 | null | 62.1 | Palliative (P) | 2015-05-04 | 2015-06-30 | IMATINIB | 02 | N | 330024785 | UKALL2011 |
| 330005763 | 330002737 | 1.56 | 55.7 | Curative (C) | 2015-02-24 | 2015-02-25 | Chlorambucil | 02 | N | 330024788 | CARBOPLATIN + RT |
| 330005764 | 330002738 | 1.54 | 61.5 | Palliative (P) | 2018-05-20 | 2018-05-20 | CARBOPLATIN + VINCRISTINE | N | N | 330024797 | ICON TRIAL |
| 330005765 | 330007493 | null | 58.1 | Curative (C) | 2017-09-27 | 2017-10-04 | Chlorambucil | null | null | 330024798 | IMATINIB |
| 330005766 | 330007493 | null | 63 | Curative (C) | 2016-08-30 | 2016-12-23 | UKALL14- Ph 1 Induction | N | N | 330024798 | CISPLATIN + FLUOROURACIL + RT |
| 330005767 | 330002739 | 0 | 0 | Palliative (P) | 2012-01-12 | 2014-08-30 | Mitotane 3 - 3.5g | N | N | 330024811 | VIDE |
| 330005768 | 330002739 | 1.69 | 121.6 | Curative (C) | 2015-10-19 | 2015-11-01 | RUXOLITINIB | N | N | 330024811 | CAPECITABINE + MITOMYCIN + RT |
| 330005769 | 330002740 | 1.86 | 90.8 | Curative (C) | null | 2013-05-08 | Cyclophos + Dex + Lenalidomide | null | null | 330024819 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 330005770 | 330002741 | 1.63 | 60.2 | Palliative (P) | 2018-02-08 | 2018-02-18 | Cisplatin+Doxorubicin+Etoposide 28d | N | N | 330024824 | PACLITAXEL |
| 330005771 | 330002741 | null | 71.4 | Curative (C) | 2013-06-20 | 2013-07-01 | Cisplatin + Docetaxel | 02 | N | 330024824 | CAPECITABINE + CISPLATIN |
| 330005772 | 330002742 | 1.72 | 68.8 | Curative (C) | 2013-12-22 | 2013-12-29 | CHLORAMBUCIL + RITUXIMAB | N | N | 330024826 | CARBOPLATIN + CETUXIMAB + FU |
| 330005773 | 330002743 | 1.66 | 55 | Palliative (P) | 2017-04-08 | 2017-04-25 | Temozolomide 150mg/m2 | 2 | N | 330024829 | CISPLATIN + FLUOROURACIL + RT |
| 330005774 | 330002744 | 0 | 25.6 | Disease modification (D) | null | 2015-11-08 | Doxorubicin + Olaratumab | Y | N | 330024832 | TEMOZOLOMIDE |
| 330005775 | 330002745 | 0 | 14.3 | Curative (C) | 2015-04-21 | 2015-04-27 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | N | 330024833 | METHOTREXATE HIGH DOSE |
| 330005776 | 330007496 | 1.58 | 49 | Palliative (P) | 2015-06-19 | 2015-06-22 | ECX | null | null | 330024836 | CHLORAMBUCIL |
| 330005777 | 330007496 | 1.71 | 90.3 | Curative (C) | 2014-02-02 | 2014-02-14 | AML17 TRIAL | N | N | 330024836 | FEC |
| 330005778 | 330007496 | 1.65 | 52.6 | Palliative (P) | 2013-03-21 | 2013-03-24 | Chlorambucil | 2 | null | 330024836 | DOXORUBICIN + OLARATUMAB |
| 330005779 | 330012288 | 1.79 | 79 | Palliative (P) | 2013-11-09 | 2013-11-23 | Epirubicin (weekly) | 2 | N | 330024851 | ADE |
| 330005780 | 330002746 | 1.5 | 52 | Palliative (P) | 2014-06-13 | 2014-06-17 | Doxorubicin + Olaratumab | 02 | N | 330024857 | CHLORAMBUCIL |
| 330005781 | 330007497 | 0 | 46.9 | Curative (C) | 2016-06-11 | 2016-06-11 | Capecitabine + Cisplatin | N | N | 330024860 | CYTARABINE HIGH DOSE |
| 330005782 | 330010076 | 0 | 0 | Neo-adjuvant (N) | 2015-10-28 | 2015-10-28 | Temozolomide + RT | N | N | 330024861 | CARBOPLATIN + PEMETREXED |
| 330005783 | 330002747 | 1.66 | 73 | Curative (C) | 2014-01-15 | 2014-01-16 | VAC | 02 | N | 330024862 | CAPECITABINE + OXALIPLATIN |
| 330005784 | 330002747 | 1.84 | 70.8 | Palliative (P) | 2015-01-10 | 2015-01-13 | Cisplatin + Fluorouracil + RT 5day | N | N | 330024862 | TRABECTEDIN |
| 330005785 | 330002748 | null | 111.95 | Palliative (P) | 2016-05-24 | 2016-06-08 | Capecitabine + Cisplatin | N | N | 330024864 | BEP |
| 330005786 | 330002748 | 1.73 | 90 | Neo-adjuvant (N) | 2014-12-28 | 2014-12-30 | CARBOPLATIN + RT | Y | N | 330024864 | CHLORAMBUCIL |